Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Keratoconus and Allergic Diseases Among Israeli Adolescents Between 2005 and 2013

Merdler, Ilan MD; Hassidim, Ayal MD; Sorkin, Nir MD; Shapira, Shachar MD; Gronovich, Yoav MBA; Korach, Zfania MD

doi: 10.1097/ICO.0000000000000416
Clinical Science
Buy

Purpose: The aim of this study was to evaluate the association between keratoconus (KC) and common allergic conditions, such as asthma, atopic dermatitis, and allergic rhinitis in a large-scale database–based epidemiological study.

Methods: We conducted a cross-sectional study to estimate the epidemiologic relationship between KC and allergic diseases. The study population included all Israeli adolescents who underwent medical evaluation by the Israeli Defense Force, between the years 2005 and 2013. The presence of KC was determined by corneal topography read by an ophthalmologist.

Results: A statistically significantly increased odds ratio (OR) for the presence of KC was found for asthma [OR: 2.0; 95% confidence interval (CI): 1.6–2.5; P < 0.001], allergic rhinitis (OR: 1.6; 95% CI: 1.3–2.0; P < 0.001), and the combination of allergic conjunctivitis, chronic blepharitis, and vernal keratoconjunctivitis (AC/CB/VKC), for which a particularly strong association was found (OR: 6.0; 95% CI: 4.0–9.2; P < 0.001). No significant association was found between angioedema, urticaria, history of anaphylaxis, allergy to hymenoptera sting or atopic dermatitis, and KC. After stratifying the patients according to the severity of the allergic disease, the association between severe (AC/CB/VKC) and KC was very high (OR: 36.5; 95% CI: 20.4–65.4; P < 0.001).

Conclusions: In this study, we demonstrated a substantial association between (AC/CB/VKC), asthma, allergic rhinitis, and KC, with no significant association between other allergic diseases and KC. The severity of the allergic status is without doubt associated with a greater risk of having KC. The mechanism causing this association is still unclear.

*Israeli Defense Force Medical Corps;

Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel; and

Department of Plastic Surgery, Shaare Zedek Medical Center, Jerusalem, Israel.

Reprints: Ayal Hassidim, MD, Israeli Defense Force Medical Corps, Shiler, 4b Jerusalem, Israel (e-mail: ayalha@gmail.com).

The authors have no funding or conflicts of interest to disclose.

I. Merdler and A. Hassidim contributed equally to this study.

Received December 27, 2014

Received in revised form January 27, 2015

Accepted January 28, 2015

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.